Skip to main content

Conavi Medical Corp(CNVI-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.310
Day High0.315
Open:0.315
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
GlobeNewswire
Conavi Medical Awarded 2026 TAG Innovation Award
GlobeNewswire
Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
Newsfile
Conavi Medical to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
GlobeNewswire
Conavi Medical Announces Results from Its Annual General Meeting of Shareholders
GlobeNewswire
Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights
GlobeNewswire
Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging
Newsfile
Upcoming Meeting Dates - January 26, 2026
GlobeNewswire
Conavi Medical Corp. Announces Closing of $12M Public Offering
GlobeNewswire
Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus  
GlobeNewswire
Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights
GlobeNewswire
Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants
GlobeNewswire
Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
GlobeNewswire
Conavi Expands Leadership Team to Support Next Phase of U.S. Commercialization
GlobeNewswire
Conavi Medical announces agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund
GlobeNewswire
Conavi Medical to Highlight Novasight Hybrid™ Imaging at TCT 2025
GlobeNewswire
Conavi Medical to Present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 2025
GlobeNewswire
Conavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System to US FDA for 510(k) Clearance
GlobeNewswire
Conavi Medical Reports Fiscal Q3 2025 Interim Results and Operational Highlights

Profile

Conavi Medical Corp is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its Novasight Hybrid System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.